June 2021


SURGX® is a powerful antimicrobial gel designed to reduce surgical site and post-surgical infections by destroying planktonic and biofilm encased bacteria. Using Next Science’s patented, non-toxic XBIO® technology, SURGX conforms to post-operative wounds to prevent surface attachment of free-floating bacteria, eliminate pathogens in the gel, and defend against recolonization. SURGX has broad spectrum efficacy within the gel. Testing shows up to a 7-log reduction of planktonic bacteria within 2 minutes and up to 5 days of sustained efficacy against bacterial biofilms. Due to the unique mechanism of action, there is no known resistance to the technology. SURGX is 1 last line of defense against surgical site infections.

Next Science



Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.